Saturday, July 11, 2026

Drug profile · INN

eprodisate disodium

eprodisate disodium (KIACTA) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — eprodisate disodium
Class
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

eprodisate disodium (KIACTA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN eprodisate disodium
Brand KIACTA

Approval history

Authority Status Date
EMA application withdrawn

Frequently asked questions

What is eprodisate disodium?

eprodisate disodium (KIACTA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for eprodisate disodium?

KIACTA is a marketed brand name for eprodisate disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.